Literature DB >> 31315692

Influence of Pain and Analgesia on Cancer Research Studies.

Douglas K Taylor1.   

Abstract

Mice and rats are valuable and commonly used as models for the study of cancer. The models and methods of experimentation have the potential to cause pain to some degree, and all charged with ensuring animal welfare must determine how to manage it. A commonly posed question, especially from investigators and IACUC, is whether the provision of analgesic agents will render the model invalid. Left untreated, pain is a stressor and has negative consequences, most notably immune system perturbations. In addition, analgesic agents in the opioid and NSAID drug classes exhibit immunomodulatory activity and influence processes such as cell proliferation, apoptosis, and angiogenesis that are important in cancer formation. Therefore, both pain and the agents used to alleviate it have the potential to act as confounding factors in a study. This review article presents data from both human medicine and work with animal models in an attempt to help inform discussions about the withholding of analgesic agents from animals used in cancer studies.

Entities:  

Year:  2019        PMID: 31315692      PMCID: PMC6935705          DOI: 10.30802/AALAS-CM-19-000002

Source DB:  PubMed          Journal:  Comp Med        ISSN: 1532-0820            Impact factor:   0.982


  85 in total

1.  Perioperative epidural analgesia for major abdominal surgery for cancer and recurrence-free survival: randomised trial.

Authors:  Paul S Myles; Philip Peyton; Brendan Silbert; Jennifer Hunt; John R A Rigg; Daniel I Sessler
Journal:  BMJ       Date:  2011-03-29

Review 2.  Surgery and stress promote cancer metastasis: new outlooks on perioperative mediating mechanisms and immune involvement.

Authors:  Elad Neeman; Shamgar Ben-Eliyahu
Journal:  Brain Behav Immun       Date:  2012-04-04       Impact factor: 7.217

Review 3.  Cancer mouse models: past, present and future.

Authors:  Walid T Khaled; Pentao Liu
Journal:  Semin Cell Dev Biol       Date:  2014-04-06       Impact factor: 7.727

Review 4.  Aspirin in the chemoprevention of colorectal neoplasia: an overview.

Authors:  Andrew T Chan; Nadir Arber; John Burn; Whay Kuang Chia; Peter Elwood; Mark A Hull; Richard F Logan; Peter M Rothwell; Karsten Schrör; John A Baron
Journal:  Cancer Prev Res (Phila)       Date:  2011-11-14

5.  Celecoxib inhibits prostate cancer growth: evidence of a cyclooxygenase-2-independent mechanism.

Authors:  Manish I Patel; Kotha Subbaramaiah; Baoheng Du; Mindy Chang; Peiying Yang; Robert A Newman; Carlos Cordon-Cardo; Howard T Thaler; Andrew J Dannenberg
Journal:  Clin Cancer Res       Date:  2005-03-01       Impact factor: 12.531

6.  Morphine attenuates surgery-induced enhancement of metastatic colonization in rats.

Authors:  Gayle Giboney Page; Shamgar Ben-Eliyahu; Raz Yirmiya; John C Liebeskind
Journal:  Pain       Date:  1993-07       Impact factor: 6.961

7.  The impact of the opioids fentanyl and morphine on nociception and bone destruction in a murine model of bone cancer pain.

Authors:  Mohammed El Mouedden; Theo Frans Meert
Journal:  Pharmacol Biochem Behav       Date:  2007-04-05       Impact factor: 3.533

8.  Morphine analgesia suppresses tumor growth and metastasis in a mouse model of cancer pain produced by orthotopic tumor inoculation.

Authors:  Takashi Sasamura; Shigenobu Nakamura; Yuko Iida; Hideki Fujii; Jun Murata; Ikuo Saiki; Hiroshi Nojima; Yasushi Kuraishi
Journal:  Eur J Pharmacol       Date:  2002-04-26       Impact factor: 4.432

9.  Aspirin induces apoptosis in vitro and inhibits tumor growth of human hepatocellular carcinoma cells in a nude mouse xenograft model.

Authors:  Mohammad Akbar Hossain; Dong Hwan Kim; Jung Yoon Jang; Yong Jung Kang; Jeong-Hyun Yoon; Jeon-Ok Moon; Hae Young Chung; Gi-Young Kim; Yung Hyun Choi; Bryan L Copple; Nam Deuk Kim
Journal:  Int J Oncol       Date:  2011-12-15       Impact factor: 5.650

10.  Do stress responses promote leukemia progression? An animal study suggesting a role for epinephrine and prostaglandin-E2 through reduced NK activity.

Authors:  Shelly Inbar; Elad Neeman; Roi Avraham; Marganit Benish; Ella Rosenne; Shamgar Ben-Eliyahu
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

View more
  2 in total

1.  'Invisible actors'-How poor methodology reporting compromises mouse models of oncology: A cross-sectional survey.

Authors:  Elizabeth A Nunamaker; Penny S Reynolds
Journal:  PLoS One       Date:  2022-10-20       Impact factor: 3.752

2.  Prevention of Acute Postoperative Pain in Breast Cancer: A Comparison between Opioids versus Ketamine in the Intraoperatory Analgesia.

Authors:  Mirian López; María Luz Padilla; Blas García; Javier Orozco; Ana María Rodilla
Journal:  Pain Res Manag       Date:  2021-11-17       Impact factor: 3.037

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.